Cytokine controlling device, treating device and treating method
CA 2474655 A1 · Owner: Nippon Sigmax Co. Ltd. · Inventors: Shinnabe, Hideyuki; Kikukawa, Tadahiro; Arahata, Susumu
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
An electromagnetic wave radiation unit (1) formed by winding a radiating coil (1-2) around a coil bobbin (1-1) is provided in a case (2). Electric current (for example, resonance frequency of 60 kHz resonance current of 0.95 mA) is , supplied from a power supply unit (3) to the radiating coil (1-2) via a resonance circuit (4). Accordingly, a feeble electromagnetic wave is emitted from the radiating coil (1-2) to form an electromagnetic field (for example magnetic flux density 6.7 nT, electric field intensity 0.42 V/m) suitable for treating at a P-point. When an affected part is set at the P-point and in the vicinity thereof, a cytokine secretion is controlled. It is confirmed that …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 27, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 27, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 27, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.